InvestorsHub Logo

Lorie3168

09/23/19 10:49 AM

#245251 RE: CherryTree1 #245247

If chemo is their current business model completely. What do you consider Keytruda to be??? I will add the last 10 years in cancer treatment has brought forward very STRONG evidence that immuno therapy is the path going forward. Dont you think Big Pharma knows if they don’t adjust their business models they will be eating dirt?? Don’t you think, as the FDA is currently adjusting their protocols in reference to this new science, it is evident that these big companies will and HAVE as well. Also though I get the idea of going it alone for NWBO. I CANT see it! LP is getting up there in age, I’ve said this before. That lady has been beatin down yet she hammers along. She is in the last mile of a marathon. IMO she is ready. If she wins with the results we expect. She has achieved the greatest feat in cancer treatment to date. What more is there? With all do respect to you and your opinion.

sentiment_stocks

09/23/19 1:15 PM

#245273 RE: CherryTree1 #245247

Merck’s temador/temazolmide will be considered a part of the DCVax-L treatment based on the trial, so for the treatment, their product would still be part of the process. As has been stated numerous times here, it’s possible that may change or evolve in the treatment of unmethylated GBM but for the most part, it’ll remain part of the treatment, thus remain consistent with the treatment model. That’s what I think with regards to GBM treatment anyway. :)